Observational Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Nov 6, 2023; 11(31): 7593-7609
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7593
Table 1 The addresses of databases
Table 2 Active ingredients and absorption, distribution, metabolism and excretion parameters of Liu-Wei-Bu-Qi capsule
No.
Compound
PubChem CID
ADMET-SOLUBLITY-level
ADMET-absorption-level
Herb
SSS1Arachidonate531254221SSS
SSS2Celabenzine44284730SSS
SSS3Deoxyharringtonine28534220SSS
SSS4Dianthramine44156231SSS
SSS5Frutinone A44196520SSS
SSS6Ginsenoside rh211930722SSS
SSS7Girinimbine9694310SSS
SSS8Gomisin B643857211SSS
SSS9Kaempferol528086330SSS
SSS10Maackiain9151020SSS
SSS11Malkangunin9047315530SSS
SSS12Panaxadiol7349810SSS
SSS13Protopine497020SSS
SSS14Suchilactone13235084020SSS
ZHQ13,9,10-Trimethoxypterocarpan1568965520ZHQ
ZHQ27-O-methylisomucronulatol1568965220ZHQ
ZHQ3Antibiotic FA 209710205989630ZHQ
ZHQ4Betulinic acid64971 12ZHQ
ZHQ5Calycosin528044830ZHQ
ZHQ6Formononetin528037830ZHQ
ZHQ7Hederagenin7329911ZHQ
ZHQ8Isoflavanone16076720ZHQ
ZHQ9Isorhamnetin528165430ZHQ
ZHQ10Kaempferol528086330ZHQ
ZHQ11Kumatakenin531886930ZHQ
ZHQ12Quercetin528034331ZHQ
YZR1(+)-delta-cadinene44100521YZR
YZR2Caryophyllene oxide174221020YZR
YZR3Chrysin528160730YZR
YZR4Daucosterol574259022YZR
YZR5Globulol1230498520YZR
YZR6Isocyperol1407660420YZR
YZR7Linolenic acid528093421YZR
YZR8Nootkatol18264520YZR
YZR9O-cymene1070330YZR
YZR10Oleic acid44563922YZR
YZR11Protocatechuic acid7240YZR
YZR12Valencene985579521YZR
YZ14',5,7-trihydroxy-6,8-dimethyl-homoisoflavanone4688673120YZ
YZ24',5,7-trihydroxy-6-methyl-8-methoxy-homoisoflavanone4688673030YZ
YZ3N-cis-Feruloyltyramine644065930YZ
YZ4P-Coumaroyltyramine537294530YZ
RG1(-)-alpha-cedrene643101520RG
RG2(-)-Caryophyllene oxide174221020RG
RG3()-Sativene1127574220RG
RG4(+)-Aromadendrene1109573420RG
RG5Beta-Cubebene9308120RG
RG6Copaene1972520RG
RG7Diisobutyl phthalate678220RG
RG8Junipene179622020RG
RG9Ledene1091065320RG
RG10Linoleic acid528045021RG
RG11Oleic acid44563922RG
CP15,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one67615230CP
CP2Citromitin1230328720CP
CP3Naringetol93230CP
CP4Nobiletin7234420CP
Table 3 Analysis of topological parameters of key targets
Name
Closeness
Betweenness
Degree
TP530.8395060.09515556
EGFR0.7906980.05178251
ALB0.7816090.07752650
ESR10.7472530.05475947
HSP90AA10.7640450.07427447
SRC0.739130.03549945
HIF1A0.7311830.02356144
MAPK30.7234040.03333243
TNF0.7083330.02776841
MAPK10.6601940.01839334
PTGS20.6601940.01325234
SMAD30.6355140.00727230
AR0.6181820.00502329
STAT10.6238530.0051429
MMP90.629630.00642729
IGF1R0.6238530.0041328
Table 4 Kyoto Encyclopedia of Genes and Genomes pathway enrichment information
Pathway
Count
P value
Estrogen signaling pathway111.09E-08
Thyroid hormone signaling pathway105.77E-08
VEGF signaling pathway75.6E-07
Toll-like receptor signaling pathway81.92E-06
Prolactin signaling pathway72.44E-06
FoxO signaling pathway81.27E-05
PI3K-Akt signaling pathway133.76E-05
HIF-1 signaling pathway74.45E-05
Sphingolipid signaling pathway75.48E-05
Neurotrophin signaling pathway75.77E-05
Table 5 Molecular docking for key targets and their related compounds
Targets
PDB ID
Compounds
Binding energy (kcal/mol)
TP534MZRprotocatechuic acid-42.1348
ALB4BKEDianthramine-49.0138
ESR14ZNHquercetin-37.218
kaempferol-37.1051
HSP90AA13WQ9quercetin-40.1408
kaempferol-38.241
SRC1Y57quercetin-37.7868
HIF1A1L8Cquercetin-38.3202
kaempferol-49.377
MAPK32ZOQquercetin-61.2015
TNF2E7Aquercetin-50.4514
MAPK11TVOformononetin-48.1226